This hypothesis was suggested by Seedhouse et al. who investigated the association between XRCC1 polymorphisms and secondary (treatment-related) leukemia and found a similar inverse association between cancer risk and XRCC1 polymorphism (Seedhouse et al., 2002). This evidence concerns the gene XRCC1 and leukemia.